A thorough neurologic examination is necessary with particular emphasis on the mental status examination.

However, definitive chronic traumatic encephalopathy diagnosis is only through post-mortem autopsy and facilitated by immunohistochemistry for p-tau.

Recent advances in the imaging armamentarium such as FDDNP PET and biomarkers such as CCL11 and CSF sTREM2 have shown promises in providing valuable input for supporting the diagnosis.

Recently, a pivotal finding of a characteristic hydrophobic cavity formed within the Î²-helix of tau filaments from CTE has paved newer insights in finding new targets in early diagnosis of the condition.